UBS AM’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-2,344
| Closed | -$414K | – | 2700 |
|
2023
Q2 | $414K | Hold |
2,344
| – | – | ﹤0.01% | 2378 |
|
2023
Q1 | $414K | Hold |
2,344
| – | – | ﹤0.01% | 2378 |
|
2022
Q4 | $906K | Buy |
2,344
+14
| +0.6% | +$5.41K | ﹤0.01% | 1891 |
|
2022
Q3 | $785K | Buy |
2,330
+777
| +50% | +$262K | ﹤0.01% | 2109 |
|
2022
Q2 | $511K | Hold |
1,553
| – | – | ﹤0.01% | 2305 |
|
2022
Q1 | $679K | Hold |
1,553
| – | – | ﹤0.01% | 2336 |
|
2021
Q4 | $681K | Hold |
1,553
| – | – | ﹤0.01% | 2411 |
|
2021
Q3 | $864K | Sell |
1,553
-134
| -8% | -$74.5K | ﹤0.01% | 2246 |
|
2021
Q2 | $867K | Buy |
1,687
+4
| +0.2% | +$2.06K | ﹤0.01% | 2284 |
|
2021
Q1 | $1.32M | Buy |
1,683
+28
| +2% | +$21.9K | ﹤0.01% | 1951 |
|
2020
Q4 | $901K | Hold |
1,655
| – | – | ﹤0.01% | 2043 |
|
2020
Q3 | $758K | Buy |
1,655
+685
| +71% | +$314K | ﹤0.01% | 1953 |
|
2020
Q2 | $597K | Buy |
970
+89
| +10% | +$54.8K | ﹤0.01% | 2041 |
|
2020
Q1 | $419K | Sell |
881
-57
| -6% | -$27.1K | ﹤0.01% | 2039 |
|
2019
Q4 | $544K | Buy |
938
+48
| +5% | +$27.8K | ﹤0.01% | 2199 |
|
2019
Q3 | $586K | Buy |
890
+427
| +92% | +$281K | ﹤0.01% | 2206 |
|
2019
Q2 | $358K | Sell |
463
-331
| -42% | -$256K | ﹤0.01% | 2346 |
|
2019
Q1 | $561K | Buy |
794
+436
| +122% | +$308K | ﹤0.01% | 2066 |
|
2018
Q4 | $168K | Sell |
358
-228
| -39% | -$107K | ﹤0.01% | 2441 |
|
2018
Q3 | $505K | Hold |
586
| – | – | ﹤0.01% | 2082 |
|
2018
Q2 | $404K | Buy |
+586
| New | +$404K | ﹤0.01% | 2189 |
|
2017
Q4 | – | Sell |
-3,962
| Closed | -$1.95M | – | 2606 |
|
2017
Q3 | $1.95M | Hold |
3,962
| – | – | ﹤0.01% | 1416 |
|
2017
Q2 | $2.19M | Sell |
3,962
-3,969
| -50% | -$2.2M | ﹤0.01% | 1329 |
|
2017
Q1 | $5.25M | Buy |
+7,931
| New | +$5.25M | 0.01% | 1008 |
|
2016
Q2 | – | Sell |
-300
| Closed | -$67K | – | 2642 |
|
2016
Q1 | $67K | Hold |
300
| – | – | ﹤0.01% | 2602 |
|
2015
Q4 | $182K | Buy |
+300
| New | +$182K | ﹤0.01% | 2559 |
|